- Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
- Predictive Oncology to Participate in Upcoming Investor Conferences
- Predictive Oncology to Participate in Upcoming San Francisco Conferences
- Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
- Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
- Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
- Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
More ▼
Key statistics
On Tuesday, Predictive Oncology Inc (POAI:NAQ) closed at 1.29, 15.18% above the 52 week low of 1.12 set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.20 |
---|---|
High | 1.38 |
Low | 1.18 |
Bid | 1.26 |
Offer | 1.29 |
Previous close | 1.18 |
Average volume | 52.10k |
---|---|
Shares outstanding | 4.06m |
Free float | 3.92m |
P/E (TTM) | -- |
Market cap | 4.79m USD |
EPS (TTM) | -3.48 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 21:00 BST.
More ▼